Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Pancreatic cancer risk doubled by two sugary soft drinks a week

  • Comment

As little as two sugary soft drinks consumed a week can almost double the risk of developing pancreatic cancer, one of the most deadly forms of cancer, a study found.

Scientists believe the high sugar content of many soft drinks may explain the trend.

Since pancreatic cancer is relatively rare - affecting around 7,600 people each year in the UK - the absolute risk from soft drinks is small.

However those diagnosed with the disease have a poor prognosis. Only 2% to 3% of patients in the UK survive as long as five years.

Researchers based their findings on more than 60,500 participants recruited for a large-scale health study in Singapore.

Over the course of 14 years, 140 of the volunteers were diagnosed with pancreatic cancer.

People who consumed two or more soft drinks a week - averaging five in total - had an 87% increased risk of developing the disease compared with those who did not.

In general the “soft drinks” concerned were of the fizzy, sugar-sweetened variety.

No association was seen between the consumption of fruit juice and pancreatic cancer.

Study leader Dr Mark Pereira, from the School of Public Health at the University of Minnesota in the US, said: “The high levels of sugar in soft drinks may be increasing the level of insulin in the body, which we think contributes to pancreatic cancer cell growth.

“Singapore is a wealthy country with excellent healthcare. Favourite pastimes are eating and shopping, so the findings should apply to other Western countries.”

The research is published today in the journal Cancer, Epidemiology, Biomarkers & Prevention.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.